IronBridge Capital Management’s Integra LifeSciences IART Stock Holding History

IronBridge Capital Management’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	$5.24M	Sell	124,372 -12,020	-9%	-$514K	0.32%	113
2016 Q4	$5.85M	Sell	136,392 -700	-0.5%	-$28.5K	0.26%	101
2016 Q3	$5.66M	Buy	137,092 +5,672	+4%	+$238K	0.26%	106
2016 Q2	$5.24M	Buy	131,420 +20,980	+19%	+$755K	0.23%	116
2016 Q1	$3.72M	Buy	110,440 +22,140	+25%	+$690K	0.15%	140
2015 Q4	$2.99M	Buy	+88,300	New	+$2.76M	0.12%	141

Other funds holding IART

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

IronBridge Capital Management's IART Position: Q1 2017 in Review

IronBridge Capital Management reduced its Integra LifeSciences (IART) stake by 8.8% in Q1 2017, selling an estimated $514K and leaving 124,372 shares worth $5.24M. The position accounts for 0.32% of the portfolio, ranked #113.

IronBridge Capital Management first reported a position in IART in Q4 2015 and has held it in 6 quarters since. The position peaked at $5.85M in Q4 2016. 237 funds tracked by Wall St. Rank hold IART as of Q1 2017.

IronBridge Capital Management held 124,372 shares of Integra LifeSciences worth $5.24M as of Q1 2017.
IronBridge Capital Management sold 12,020 Integra LifeSciences shares in Q1 2017, an estimated $514K.
Integra LifeSciences made up 0.32% of IronBridge Capital Management's portfolio in Q1 2017, its #113 holding.
IronBridge Capital Management first reported a position in Integra LifeSciences in Q4 2015 and has held it in 6 quarters since.
IronBridge Capital Management's Integra LifeSciences position peaked at $5.85M in Q4 2016.
237 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2017.

Based on IronBridge Capital Management's 13F filing for Q1 2017, filed 10 May 2017.